Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 432,000 | 319,000 | 188,000 | 549,000 | 764,000 |
| Receivables | 1,456,000 | 1,419,000 | 1,404,000 | 1,304,000 | 1,376,000 |
| Inventories | 186,000 | 187,000 | 189,000 | 188,000 | 184,000 |
| TOTAL | $2,407,000 | $2,198,000 | $2,075,000 | $2,392,000 | $2,623,000 |
| Non-Current Assets | |||||
| PPE Net | 2,145,000 | 2,120,000 | 2,098,000 | 2,113,000 | 2,093,000 |
| Investments And Advances | 137,000 | 136,000 | 134,000 | 123,000 | 125,000 |
| Intangibles | 10,563,000 | 10,589,000 | 10,574,000 | 10,619,000 | 10,321,000 |
| Other Non-Current Assets | 945,000 | 926,000 | 916,000 | 906,000 | 933,000 |
| TOTAL | $13,790,000 | $13,771,000 | $13,722,000 | $13,761,000 | $13,472,000 |
| Total Assets | $16,197,000 | $15,969,000 | $15,797,000 | $16,153,000 | $16,095,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 504,000 | 504,000 | 1,000 | 602,000 | 603,000 |
| Accounts payable and accrued liabilities | 1,457,000 | 1,349,000 | 1,267,000 | 1,394,000 | 1,313,000 |
| TOTAL | $2,134,000 | $2,024,000 | $1,441,000 | $2,169,000 | $2,092,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,171,000 | 5,169,000 | 5,858,000 | 5,615,000 | 5,648,000 |
| Other Non-Current Liabilities | 1,583,000 | 1,497,000 | 1,521,000 | 1,542,000 | 1,503,000 |
| TOTAL | $6,768,000 | $6,680,000 | $7,394,000 | $7,171,000 | $7,162,000 |
| Total Liabilities | $8,902,000 | $8,704,000 | $8,835,000 | $9,340,000 | $9,254,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,242 | 111,823 | 111,636 | 110,978 | 111,615 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 9,837,000 | 9,682,000 | 9,490,000 | 9,360,000 | 9,222,000 |
| Other shareholders' equity | -3,000 | 21,000 | -50,000 | -53,000 | 17,000 |
| TOTAL | $7,295,000 | $7,265,000 | $6,962,000 | $6,813,000 | $6,841,000 |
| Total Liabilities And Equity | $16,197,000 | $15,969,000 | $15,797,000 | $16,153,000 | $16,095,000 |